Cardiac Biomarkers

Global Market Trajectory & Analytics

MCP-1632

EXECUTIVE ENGAGEMENTS

POOL

5667
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

907
Interactions with Platform & by Email

PARTICIPANTS

172
Unique # Participated

VALIDATIONS

37
Responses Validated*

COMPANIES

39
Responses Validated*
* Login for a full stack data experience

DATE

JAN 2022

TABLES

202

PAGES

272

EDITION

16

PRICE

USD 5450

CODE

MCP-1632


COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)

S M N T

%

VALIDATED RESEARCH *

S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T
S M N T

* S = Strong; M = Moderate; N = Niche; T= Trivial (<1%)
* Login to Participate & View Data Stacks
* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlassTM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.
View All Companies...

PARTICIPATE NOW!
  

HIGHLIGHTS & REPORT INDEX

Amid the COVID-19 crisis, the global market for Cardiac Biomarkers estimated at US$6.2 Billion in the year 2020, is projected to reach a revised size of US$10.8 Billion by 2027, growing at aCAGR of 8.1% over the period 2020-2027. Laboratory Testing, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$6.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Point-of-Care Testing segment is readjusted to a revised 8.8% CAGR for the next 7-year period.
The Cardiac Biomarkers market in the U.S. is estimated at US$1.7 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.4 Billion by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.4% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

SELECT PLAYERS

Abbott Diagnostics; Beckman Coulter Inc.; BG Medicine; bioMérieux SA; Boditech Med Inc.; Labsystems Diagnostics OY; LifeSign LLC; LSI Medience Corp.; Merck KGaA; Ortho-Clinical Diagnostics Inc.; Quidel Corporation; Randox Laboratories; Response Biomedical Corp.; Roche Diagnostics Corp.; Siemens Healthineers

SEGMENTS

» Location Type (Laboratory Testing, Point-of-Care Testing)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » Spain » Russia » and Rest of Europe » Asia-Pacific » Australia » India » South Korea » and Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » and Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » United Arab Emirates » and Rest of Middle East » and Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
A Curtain Raiser
Major Cardiac Markers and their Properties
Recent Market Activity
Market Set to Record Strong Growth Led by Advancements in Cardiac Biomarker Combinations
North America Corners Biggest Slice, Asia-Pacific to Dictate Market Momentum
Laboratory Testing Remains Gold Standard, POC Testing Rapidly Gains Traction
Analysis by Type of Cardiac Biomarker Assay/Test
Competitive Landscape
Intense Competition among Players in the Cardiac Diagnostics Market
Leading Vendors Focus on Curtailing Turnaround Time of POC Cardiac Testing Kits
Cardiac Markers Point-Of-Care Testing (POC) Cardiac Testing Segment: Major Players and their Operating Brands
Other Recent Innovations
Lipid Biomarker Panel to Detect HfrEF
VectraplexECG System with CEB® Cardiac Electrical Biomarker
Cardiac Biomarkers on Smartphone
Stringent Regulations and Other Challenges
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
Abbott Diagnostics, Inc. (USA)
Quidel Corporation (USA)
Beckman Coulter, Inc. (USA)
BG Medicine, Inc. (USA)
biomérieux SA (France)
Boditech Med Inc. (South Korea)
Labsystems Diagnostics OY (Finland)
LifeSign LLC (USA)
LSI Medience Corporation (Japan)
Ortho-Clinical Diagnostics, Inc. (USA)
Randox Laboratories Ltd. (UK)
Response Biomedical Corp. (Canada)
Roche Diagnostics (Switzerland)
Siemens Healthineers (USA)
Merck KGaA (Germany)
3. MARKET TRENDS & DRIVERS
The Grim Reality of Mounting Economic and Social Burden of Cardiovascular Disease
Population Explosion, Ballooning Geriatric Populace, Longer Life Expectancy Contributing to Rising Tide of CVDs
Cardiac Biomarkers Hold the Key to Timely, Accurate Diagnosis & Prognosis
Commercialization of Novel Biomarkers to Drive Market Growth
Personalized Medicine, Companion Diagnostics Open Up Opportunities for Cardiac Biomarker Developers
Cardiac Biomarkers - A Powerful Tool for Patient Triaging
Cardiac Biomarkers Market Transitions from Mono-Marker to Multi-Marker Assays
Government Support Instrumental for Boosting Market Momentum
Secretoneurin Biomarker - a Potential Game Changer for Diagnosis of Cardiac Arrhythmias
High-Performance Techniques Drive Biomarker Discovery in Cardiology
Biomarkers for Acute Coronary Syndromes (ACS): A Leading Segment
Biomarkers - A Promising Diagnostic Tool for ACS
Biomarker Discovery for ACS to Undergo Significant Changes
Cardiac Biomarker Play Critical Role in Stroke Diagnosis
Cardiac Biomarkers to Find a Place in Neonatal Diagnosis and Treatment
Specificity, Sensitivity, Side Effects, Cost Concerns Hinder Market Growth
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Cardiac Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Laboratory Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Laboratory Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Point-of-Care Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Point-of-Care Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Point-of-Care Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Cardiac Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Cardiac Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Cardiac Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cardiac Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Cardiac Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cardiac Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Cardiac Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cardiac Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cardiac Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Cardiac Biomarkers by Location Type - Laboratory Testing and Point-of-Care Testing Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Cardiac Biomarkers by Location Type - Percentage Breakdown of Value Sales for Laboratory Testing and Point-of-Care Testing for the Years 2012, 2020 & 2027
Total Companies Profiled: 39

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com